2023

Targeted Therapies in Psoriatic Arthritis-An Update.

Sundanum S, Orr C, Veale D.Int J Mol Sci. 2023 Mar 28;24(7):6384. doi: 10.3390/ijms24076384.PMID: 37047357 

Rheumatoid arthritis macrophages are primed for inflammation and display bioenergetic and functional alterations.

Hanlon MM, McGarry T, Marzaioli V, Amaechi S, Song Q, Nagpal S, Veale DJ, Fearon U.Rheumatology (Oxford). 2023 Jul 5;62(7):2611-2620. doi: 10.1093/rheumatology/keac640

The mammalian target of rapamycin contributes to synovial fibroblast pathogenicity in rheumatoid arthritis.

Barker BE, Hanlon MM, Marzaioli V, Smith CM, Cunningham CC, Fletcher JM, Veale DJ, Fearon U, Canavan M.Front Med (Lausanne). 2023 Feb 3;10:1029021. doi: 10.3389/fmed.2023.1029021. eCollection 2023.

Knowledge of disease, diagnosis, adherence and impact of research in an Irish cohort of patients with inflammatory arthritis.

Marzaioli V, Canavan M, Donnelly A, Wade S, Fraser A, O’Sullivan T, Harney S, Ireland A, Veale DJ, Fearon U.HRB Open Res. 2023 Apr 27;4:60. doi: 10.12688/hrbopenres.13274.2. eCollection 2021.